爱康临床研究

US · ICLR #1235 按市值排名上市于 1970

170.18 -4.95 -2.83%

实时 - 追踪5344个代码 - 心跳于529秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了3家。
机构持股总比例下降了0.6个百分点。

机构持股

机构持股比例: 106.32% -0.64pp
机构数量: 521 -3
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund90.60%

Hedge Fund9.56%

Public Company2.04%

Sovereign Wealth Fund1.10%

Government Pension Fund1.09%

Private Company1.01%

VC/PE Fund0.65%

Family Office/Trust0.25%

主要股东截至 2026-06-30

Artisan Partners Limited Partnership 11.19% · 8.64M 股

Wellington Management Group 6.90% · 5.32M 股

FMR 6.79% · 5.24M 股

Invesco Ltd. 6.72% · 5.19M 股

Harris Associates L.P. 5.79% · 4.47M 股

Brave Warrior Advisors, LLC 4.09% · 3.15M 股

Greenhaven Associates Inc 4.02% · 3.10M 股

Principal Global Investors, LLC 3.82% · 2.95M 股

MFS Investment Management 2.73% · 2.11M 股

Ruane, Cunniff & Goldfarb L.P. 2.65% · 2.05M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 25次买入 · 19次卖出

姓名	职务	持股比例
Ciaran Murray	Independent Non-Executive Chairperson	0.03%
Linda Grais	Independent Director	0.01%
Nigel Clerkin	Chief Financial Officer	0.01%
Barry Balfe	President of ICON Pharma Development Solutions	0.01%
Ronan Murphy	Lead Independent Director	0.00%
Eugene McCague	Independent Non-Executive Director	0.00%
Julie O'Neill	Independent Non-Executive Director	0.00%
John Climax	Founder & Independent Non-Executive Director	0.00%
Anne Michelle Whitaker	Non-Executive Director	0.00%
Lyons Emer	Chief Accounting Officer	0.00%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-16	Eugene McCague	Independent Non-Executive Director	Derivative Exercise and Sale	-3,255	$125.74–175.00
2026-09-16	Ronan Murphy	Lead Independent Director	Derivative Exercise and Sale	-5,005	$125.74–175.00
2026-09-15	John Climax	Founder & Independent Non-Executive Director	Derivative Exercise and Sale	-5,005	$125.74–175.00
2026-08-10	John Climax	Founder & Independent Non-Executive Director	Derivative Exercise and Sale	-841	$162.72–165.51
2026-08-10	John Climax	Founder & Independent Non-Executive Director	Intent to Sell (Form 144)	-841	$164.29
2026-08-10	Linda Grais	Independent Director	Derivative Exercise and Sale	-841	$162.72–165.51
2026-08-10	Eugene McCague	Independent Non-Executive Director	Derivative Exercise and Sale	-841	$162.72–165.51
2026-08-10	Ciaran Murray	Independent Non-Executive Chairperson	Derivative Exercise and Sale	-2,677	$162.72–165.51
2026-08-10	Ciaran Murray	Independent Non-Executive Chairperson	Intent to Sell (Form 144)	-2,677	$164.29
2026-08-10	Nigel Clerkin	Chief Financial Officer	Derivative Exercise and Sale	-2,267	$162.72–165.51
2026-08-10	Nigel Clerkin	Chief Financial Officer	Intent to Sell (Form 144)	-2,267	$164.29
2026-08-10	Ronan Murphy	Lead Independent Director	Derivative Exercise and Sale	-841	$162.72–165.51
2026-08-10	Anne Michelle Whitaker	Non-Executive Director	Derivative Exercise and Sale	-841	$162.72–165.51
2026-08-10	Anne Michelle Whitaker	Non-Executive Director	Intent to Sell (Form 144)	-841	$164.29
2026-08-10	Julie O'Neill	Independent Non-Executive Director	Derivative Exercise and Sale	-915	$162.72–165.51
2026-08-09	John Climax	Founder & Independent Non-Executive Director	Other Derivative Acquisition	+1,324	--
2026-08-09	John Climax	Founder & Independent Non-Executive Director	Derivative Exercise and Retained	+891	--
2026-08-09	Linda Grais	Independent Director	Other Derivative Acquisition	+1,324	--
2026-08-09	Linda Grais	Independent Director	Derivative Exercise and Retained	+891	--
2026-08-09	Eugene McCague	Independent Non-Executive Director	Other Derivative Acquisition	+1,324	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。